Switch to:
More From Other Websites
Alkermes Incurs Wider Q3 Loss but Revenues Grow Y/Y Oct 31 2014
Alkermes reports 3Q loss Oct 29 2014
Alkermes reports 3Q loss Oct 29 2014
Alkermes Plc Earnings Call scheduled for 8:30 am ET today Oct 29 2014
ALKERMES PLC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Oct 29 2014
Q3 2014 Alkermes Plc Earnings Release - Before Market Open Oct 29 2014
7:05 am Alkermes beats by $0.01, beats on revs; guides FY14 EPS in-line, revs in-line Oct 29 2014
Alkermes plc Reports Third Quarter 2014 Financial Results Oct 29 2014
Alkermes plc Reports Third Quarter 2014 Financial Results Oct 29 2014
Alkermes to Host Conference Call to Discuss Third Quarter 2014 Financial Results Oct 22 2014
Alkermes to Host Conference Call to Discuss Third Quarter 2014 Financial Results Oct 22 2014
Alkermes to Host Conference Call to Discuss Third Quarter 2014 Financial Results Oct 22 2014
Alkermes’ New Drug Application for Aripiprazole Lauroxil for Treatment of Schizophrenia Accepted... Oct 22 2014
Alkermes’ New Drug Application for Aripiprazole Lauroxil for Treatment of Schizophrenia Accepted... Oct 22 2014
Cramer's favorite large cap biotech plays Sep 24 2014
ALKERMES PLC. Files SEC form 8-K, Regulation FD Disclosure Sep 24 2014
Alkermes Completes Enrolment for Phase II ALKS 3831 Study Sep 04 2014
Alkermes Announces Completion of Patient Enrollment in Phase 2 Study of ALKS 3831, a Novel,... Sep 03 2014
Alkermes’ Corporate Presentation to be Webcast at the Morgan Stanley Global Healthcare Conference Sep 02 2014
Alkermes Begins a Study on ALKS7106 for Treatment of Pain Aug 27 2014


No Entry for this criteria! We are updating our databases daily, please come back later!

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK